• Register
  • Login

European Journal of Molecular & Clinical Medicine

  • Home
  • Browse
    • Current Issue
    • By Issue
    • By Subject
    • Keyword Index
    • Author Index
    • Indexing Databases XML
  • Journal Info
    • About Journal
    • Aims and Scope
    • Editorial Board
    • Publication Ethics
    • Indexing and Abstracting
    • Peer Review Process
    • News
  • Guide for Authors
  • Submit Manuscript
  • Contact Us
Advanced Search

Notice

As part of Open Journals’ initiatives, we create website for scholarly open access journals. If you are responsible for this journal and would like to know more about how to use the editorial system, please visit our website at https://ejournalplus.com or
send us an email to info@ejournalplus.com

We will contact you soon

  1. Home
  2. Volume 9, Issue 7
  3. Authors

Online ISSN: 2515-8260

Volume9, Issue7

CORRELATION OF COAGULATION MARKERS ( PT, INR, D-dimer & Factor VIII) WITH AXILLARY LYMPH NODE METASTASIS IN CARCINOMA BREAST

    Dr.Sri lakshmi Vemulapalli Dr. S.J. Bhosale

European Journal of Molecular & Clinical Medicine, 2022, Volume 9, Issue 7, Pages 5392-5410

  • Show Article
  • Download
  • Cite
  • Statistics
  • Share

Abstract

Introduction: The extracellular matrix remodeling is an important step in primary tumor growth, and metastasis. Many studies regarding carcinomas, including breast carcinoma, have suggested elevated levels of procoagulant factors and fibrinogen and fibrin degradation factors and associated fall in coagulation system inactivators. In the current study we try and correlate the coagulation markers D-dimer, Factor VIII, PT & INR in carcinoma breast patients, with advancing stages of the disease and lymph node metastasis and to look for the relation of these coagulation markers with know prognostic factors in carcinoma breast.
Methods: A total of 100 subjects (Diagnosed cases of operable carcinoma breast) were enrolled in the study from the Department of Surgery, Krishna Hospital, Karad, over the period  December 2020 to July 2022.
Results:  The above study had a mean age of 53.33yrs, with marority of the cases being of left sided breast carcinoma (58%), with majority of them belonging to the stage IIA (33%).  There was a statistically significant correlation between  the coagulation markers  D-dimer, Factor VIII, PT and INR; with progressive stage of carcinoma breast  with p value= 0.024, p value= 0.05, p value= 0.023 respectively. There was a statistically significant decrease in the coagulation markers that were noticed postoperatively (PT p value= 0.03, INR p value=0.0008, D-Dimer p value= 0.016, and Factor VIII p value=0.001 respectively.)
Conclusion: There is a statistically significant correlation between  the coagulation markers  D-dimer, Factor VIII, PT and INR; with progressive stage of carcinoma breast 
Keywords:
  • PDF (889 K)
  • XML
(2022). CORRELATION OF COAGULATION MARKERS ( PT, INR, D-dimer & Factor VIII) WITH AXILLARY LYMPH NODE METASTASIS IN CARCINOMA BREAST. European Journal of Molecular & Clinical Medicine, 9(7), 5392-5410.
Dr.Sri lakshmi Vemulapalli; Dr. S.J. Bhosale. "CORRELATION OF COAGULATION MARKERS ( PT, INR, D-dimer & Factor VIII) WITH AXILLARY LYMPH NODE METASTASIS IN CARCINOMA BREAST". European Journal of Molecular & Clinical Medicine, 9, 7, 2022, 5392-5410.
(2022). 'CORRELATION OF COAGULATION MARKERS ( PT, INR, D-dimer & Factor VIII) WITH AXILLARY LYMPH NODE METASTASIS IN CARCINOMA BREAST', European Journal of Molecular & Clinical Medicine, 9(7), pp. 5392-5410.
CORRELATION OF COAGULATION MARKERS ( PT, INR, D-dimer & Factor VIII) WITH AXILLARY LYMPH NODE METASTASIS IN CARCINOMA BREAST. European Journal of Molecular & Clinical Medicine, 2022; 9(7): 5392-5410.
  • RIS
  • EndNote
  • BibTeX
  • APA
  • MLA
  • Harvard
  • Vancouver
  • Article View: 5
  • PDF Download: 17
  • LinkedIn
  • Twitter
  • Facebook
  • Google
  • Telegram
Journal Information

Publisher:

Email:  editor.ejmcm21@gmail.com

  • Home
  • Glossary
  • News
  • Aims and Scope
  • Privacy Policy
  • Sitemap

 

For Special Issue Proposal : editor.ejmcm21@gmail.com

This journal is licensed under a Creative Commons Attribution 4.0 International (CC-BY 4.0)

Powered by eJournalPlus